about
Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)Immature truncated O-glycophenotype of cancer directly induces oncogenic featuresElucidating the role of interleukin-17F in cutaneous T-cell lymphomaJak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaVascular endothelial growth factor receptor-3 expression in mycosis fungoides.COX-2 is a novel target in therapy of mycosis fungoides.IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.COX-2-dependent PGE(2) acts as a growth factor in mycosis fungoides (MF).
P50
Q24629558-F52F58C9-21EB-4F30-899C-3455D3CC5F7FQ34314283-77C9B0B0-F8F3-4E43-8B7D-77B9565643C7Q37216178-5763DF02-0778-4C8B-BA16-B0C16AFBB0BDQ38846167-07708724-3F77-4541-B3D2-3FEE4E4CE50BQ39285766-75929479-EBDE-4F5A-AD4C-B9F9F21ECFE5Q42873280-379726B2-F320-42A4-B3D4-D00F22DC4D5EQ44311617-0F85DDA2-59FB-49CD-A08B-7F80CD8A223EQ44374191-C428B29B-4EF3-4885-81A6-DC7F679AB5D4Q53299556-1C6062F3-13EE-4AA9-8BEF-14EF149F9F61
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9479-8513
@en
name
Katharina L Kopp
@ast
Katharina L Kopp
@en
Katharina L Kopp
@nl
type
label
Katharina L Kopp
@ast
Katharina L Kopp
@en
Katharina L Kopp
@nl
prefLabel
Katharina L Kopp
@ast
Katharina L Kopp
@en
Katharina L Kopp
@nl
P106
P31
P496
0000-0002-9479-8513